As previously reported in the Phase 2 ColdU and SD study, up to 53% of patients with ColdU and 58% with SD achieved complete response (negative provocation test) at Week 12 (primary endpoint analysis) ...
Patient dosing in the FREEDOM2 10 mg/kg cohort is proceeding in Canada and the UK, with data expected in 2H 2026 –– FREEDOM2 trial open in South Korea, Australia, and New Zealand –– Well-funded with ...
Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 1:20 PM ESTCompany ParticipantsTom Frohlich ...
Maya Jewell Zeller might say she grew up feral. Or she grew up unconventionally. She wouldn’t say she grew up homeless. In ...
Plan your Fetch Charlotte schedule with these lectures to watch. The dvm360 team is heading to Charlotte, North Carolina! From March 13-14, 2026, dvm360’s team—our amazing faculty, exhibitors, and ...
Lacy Norman has long been interested in helping the human body move and feel better. “I wanted to be a scientist and a doctor,” she said. “My mother always loved plants and natural medicine.” Norman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results